ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

Diltiazem HCl Injection
CHF and arrhythmias
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

Diltiazem HCl Injection Rx

Generic Name and Formulations:
Diltiazem HCl 5mg/mL; soln for IV inj or infusion after dilution.

Company:
Various generic manufacturers

Therapeutic Use:

Indications for Diltiazem HCl Injection:

Temporary control of rapid ventricular rate in atrial fibrillation or flutter. Rapid conversion of paroxysmal supraventricular tachycardias (PSVT) to sinus rhythm.

Adult:

Direct IV single injections (bolus): initially 0.25mg/kg over 2 minutes; if needed, may give second dose (0.35mg/kg) after 15 minutes; subsequent bolus doses should be individualized. If continuous IV infusion is needed, begin immediately after bolus administration. Initial infusion rate: 10mg/h; may increase in 5mg/h increments up to 15mg/h. May be maintained for up to 24 hours.

Children:

Not recommended.

Contraindications:

Sick sinus syndrome or 2nd- or 3rd-degree AV block (unless paced). Severe hypotension. Cardiogenic shock. Concomitant IV β-blockers. Atrial fibrillation or flutter associated with an accessory bypass tract such as in Wolff-Parkinson-White syndrome or short PR syndrome. Ventricular tachycardia.

Warnings/Precautions:

Have resuscitative equipment readily available. CHF. Renal or hepatic impairment. Hemodynamically compromised. Continuously monitor ECG and blood pressure. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

See Contraindications. Possible bradycardia, AV block, and/or depression of contractility with concomitant oral β-blockers. Additive effects with agents known to affect cardiac conduction. Avoid concomitant CYP3A4 inducers (eg, rifampin). Potentiated by cimetidine; may need to adjust diltiazem dose. May potentiate anesthetics, benzodiazepines, buspirone, carbamazepine, cyclosporine, quinidine; monitor.

Pharmacological Class:

Calcium channel blocker (CCB) (benzothiazepine).

Adverse Reactions:

Hypotension, inj site reactions (eg, itching, burning), vasodilation, arrhythmia; dermatological events (eg, erythema multiforme, exfoliative dermatitis; discontinue if occurs), hepatotoxicity, ventricular premature beats.

Note:

Formerly known under the brand name Cardizem.

How Supplied:

Contact supplier.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs